FDA Inspection 771722 — Central California Blood Center

Central California Blood Center — FEI 2970324

The FDA completed an inspection of Central California Blood Center on February 1, 2012 in Fresno, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 1, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fresno, CA (United States)